How do you think the new GigE standards will influence the machine vision industry?
Respond or ask your question now!
2005 DEC 29 - (NewsRx.com) -- CompuMed, Inc., (CMPD), a developer of computer-aided diagnostic (CAD) solutions for the healthcare industry, and FUJIFILM Medical Systems USA, Inc., (FUJIY) announced the signing of a licensing agreement that enables FUJIFILM Medical Systems USA, Inc., to integrate CompuMed's proprietary OsteoGram osteoporosis screening software with its computed radiography (CR) systems, as well as future CR mammography systems.
Under the terms of the 5-year agreement, Fuji will place an initial order for 10 OsteoGram systems and then license and distribute the OsteoGram on existing and new CR systems, as well as future mammography platforms in the United States. Fuji states it has the largest installed base of CR systems in the U.S., and currently markets its products through a direct sales organization and a nationwide network of imaging distributors.
The OsteoGram is a medical image-processing system that enables healthcare providers to screen, diagnose, and monitor osteoporosis using digital images from filmless x-ray equipment or conventional, film-based hand x-rays. The system analyzes such images via proprietary software that produces a bone mineral density report.
"Integrating CompuMed's unique OsteoGram system with Fuji's computed radiology equipment will enable women to get screened for osteoporosis at the same time they undergo a mammogram or other common medical imaging exam," said John Strauss, Fuji's director of marketing for imaging systems. "We believe integrating these systems will serve an important public health need by making osteoporosis screening more convenient for patients, while also helping healthcare providers add services and improve workflow."
This article was prepared by Women's Health Weekly editors from staff and other reports. Copyright 2005, Women's Health Weekly via NewsRx.com.